28 related articles for article (PubMed ID: 10838658)
1. Identification of peptides applicable as vaccines for HLA-A26-positive cancer patients.
Niu Y; Terasaki Y; Komatsu N; Noguchi M; Shichijo S; Itoh K
Cancer Sci; 2009 Nov; 100(11):2167-74. PubMed ID: 19689476
[TBL] [Abstract][Full Text] [Related]
2. Expression of the SART-1 antigens in uterine cancers.
Matsumoto H; Shichijo S; Kawano K; Nishida T; Sakamoto M; Itoh K
Jpn J Cancer Res; 1998 Dec; 89(12):1292-5. PubMed ID: 10081490
[TBL] [Abstract][Full Text] [Related]
3. Identification of an epitope derived from CML66, a novel tumor-associated antigen expressed broadly in human leukemia, recognized by human leukocyte antigen-A*2402-restricted cytotoxic T lymphocytes.
Suemori K; Fujiwara H; Ochi T; Azuma T; Yamanouchi J; Narumi H; Yakushijin Y; Hato T; Hasegawa H; Yasukawa M
Cancer Sci; 2008 Jul; 99(7):1414-9. PubMed ID: 18422754
[TBL] [Abstract][Full Text] [Related]
4. Database of T cell-defined human tumor antigens: the 2013 update.
Vigneron N; Stroobant V; Van den Eynde BJ; van der Bruggen P
Cancer Immun; 2013; 13():15. PubMed ID: 23882160
[TBL] [Abstract][Full Text] [Related]
5. Inhibition of the CCR6-CCL20 axis prevents regulatory T cell recruitment and sensitizes head and neck squamous cell carcinoma to radiation therapy.
Rutihinda C; Haroun R; Saidi NE; Ordoñez JP; Naasri S; Lévesque D; Boisvert FM; Fortier PH; Belzile M; Fradet L; Hubert-Tremblay V; Turgeon GA; Wang CS; Delage P; Rousseau É; Paquette B; Oweida AJ
Cancer Immunol Immunother; 2023 May; 72(5):1089-1102. PubMed ID: 36326893
[TBL] [Abstract][Full Text] [Related]
6. Progress in the development of immunotherapy for the treatment of patients with cancer.
Rosenberg SA
J Intern Med; 2001 Dec; 250(6):462-75. PubMed ID: 11902815
[TBL] [Abstract][Full Text] [Related]
7. [Tumor-rejection antigens expressed on human squamous cell carcinoma].
Itoh K; Nakao M; Imai Y; Toh Y; Yamana H
Hum Cell; 1995 Dec; 8(4):149-54. PubMed ID: 8721083
[TBL] [Abstract][Full Text] [Related]
8. [Human tumor-rejection antigens and peptides from genes to clinical research].
Itoh K; Yamana H; Shichijo S; Yamada A
Nihon Geka Gakkai Zasshi; 2000 Sep; 101(9):612-7. PubMed ID: 11022676
[TBL] [Abstract][Full Text] [Related]
9. Expression of the SART1 tumor rejection antigen in renal cell carcinoma.
Shintaku I; Kawagoe N; Yutani S; Hoshi S; Orikasa S; Yoshizumi O; Itoh K
Urol Res; 2000 Jun; 28(3):178-84. PubMed ID: 10929426
[TBL] [Abstract][Full Text] [Related]
10. Cytokines required for induction of histocompatibility leukocyte antigen-class I-restricted and tumor-specific cytotoxic T lymphocytes by a SART1-derived peptide.
Matsunaga K; Nakao M; Masuoka K; Inoue Y; Gouhara R; Imaizumi T; Nishizaka S; Itoh K
Jpn J Cancer Res; 1999 Sep; 90(9):1007-15. PubMed ID: 10551332
[TBL] [Abstract][Full Text] [Related]
11. Identification of a SART-1-derived peptide capable of inducing HLA-A24-restricted and tumor-specific cytotoxic T lymphocytes.
Kikuchi M; Nakao M; Inoue Y; Matsunaga K; Shichijo S; Yamana H; Itoh K
Int J Cancer; 1999 May; 81(3):459-66. PubMed ID: 10209962
[TBL] [Abstract][Full Text] [Related]
12. Expression of the tumor-rejection antigen SART1 in brain tumors.
Imaizumi T; Kuramoto T; Matsunaga K; Shichijo S; Yutani S; Shigemori M; Oizumi K; Itoh K
Int J Cancer; 1999 Dec; 83(6):760-4. PubMed ID: 10597192
[TBL] [Abstract][Full Text] [Related]
13. A gene encoding antigenic peptides of human squamous cell carcinoma recognized by cytotoxic T lymphocytes.
Shichijo S; Nakao M; Imai Y; Takasu H; Kawamoto M; Niiya F; Yang D; Toh Y; Yamana H; Itoh K
J Exp Med; 1998 Feb; 187(3):277-88. PubMed ID: 9449708
[TBL] [Abstract][Full Text] [Related]
14. Induction of human leukocyte antigen-A26-restricted and tumor-specific cytotoxic T lymphocytes by a single peptide of the SART1 antigen in patients with cancer with different A26 subtypes.
Inoue Y; Nakao M; Matsunaga K; Kikuchi M; Gomi S; Toh U; Takamori S; Yamana H; Itoh K
J Immunother; 2000; 23(3):296-303. PubMed ID: 10838658
[TBL] [Abstract][Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
